The ROE (Return on Equity) of Inhibikase Therapeutics Inc (IKT) is -29.01%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -29.01% |
| 2023-12-31 | -173.34% |
| 2022-12-31 | -85.79% |
| 2021-12-31 | -38.50% |
| 2020-12-31 | -29.14% |
| 2019-12-31 | 127.39% |
| 2018-12-31 | 275.64% |
| 2017-12-31 | 30.56% |
| 2016-12-31 | 46.67% |